Medpace Holdings, Inc. Amortization of Intangible Assets
Medpace Holdings, Inc. (MEDP) reported Amortization of Intangible Assets of $155.00 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-07-23.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:AmortizationOfIntangibleAssets · last filed 2026-07-23
- Medpace Holdings, Inc. amortization of intangible assets for the quarter ending 2026-06-30 was $155.00K, a 34.60% decline year-over-year.
- Medpace Holdings, Inc. amortization of intangible assets for the quarter ending 2026-03-31 was $155.00K, a 34.32% decline year-over-year.
- Medpace Holdings, Inc. amortization of intangible assets for the quarter ending 2025-12-31 was $237.00K, a 34.35% decline year-over-year.
- Medpace Holdings, Inc. amortization of intangible assets for the quarter ending 2025-09-30 was $236.00K, a 34.44% decline year-over-year.
- Medpace Holdings, Inc. amortization of intangible assets for fiscal 2025 was $946.00K, a 34.44% decline from fiscal 2024.
- Medpace Holdings, Inc. amortization of intangible assets for fiscal 2024 was $1.44M, a 34.38% decline from fiscal 2023.
- Medpace Holdings, Inc. amortization of intangible assets for fiscal 2023 was $2.20M, a 34.40% decline from fiscal 2022.
- Medpace Holdings, Inc. amortization of intangible assets for fiscal 2022 was $3.35M, a 34.45% decline from fiscal 2021.
| Period end | Amortization of Intangible Assets 3 month | Amortization of Intangible Assets 6 month | Amortization of Intangible Assets 9 month | Amortization of Intangible Assets 12 month |
|---|---|---|---|---|
| 2026-06-30 | $155.00K 10-Q · filed 2026-07-23 | $310.00K 10-Q · filed 2026-07-23 | $547.00K derived: sum of 3 quarters · filed 2026-07-23 | $783.00K derived: sum of 4 quarters · filed 2026-07-23 |
| 2026-03-31 | $155.00K 10-Q · filed 2026-04-23 | $392.00K derived: sum of 2 quarters · filed 2026-04-23 | $628.00K derived: sum of 3 quarters · filed 2026-04-23 | $865.00K derived: sum of 4 quarters · filed 2026-07-23 |
| 2025-12-31 | $237.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-10 | $473.00K derived: sum of 2 quarters · filed 2026-02-10 | $710.00K derived: sum of 3 quarters · filed 2026-07-23 | $946.00K 10-K · filed 2026-02-10 |
| 2025-09-30 | $236.00K 10-Q · filed 2025-10-23 | $473.00K derived: sum of 2 quarters · filed 2026-07-23 | $709.00K 10-Q · filed 2025-10-23 | $1.07M derived: sum of 4 quarters · filed 2026-07-23 |
| 2025-06-30 | $237.00K 10-Q · filed 2026-07-23 | $473.00K 10-Q · filed 2026-07-23 | $834.00K derived: sum of 3 quarters · filed 2026-07-23 | $1.19M derived: sum of 4 quarters · filed 2026-07-23 |
| 2025-03-31 | $236.00K 10-Q · filed 2026-04-23 | $597.00K derived: sum of 2 quarters · filed 2026-04-23 | $957.00K derived: sum of 3 quarters · filed 2026-04-23 | $1.32M derived: sum of 4 quarters · filed 2026-04-23 |
| 2024-12-31 | $361.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-10 | $721.00K derived: sum of 2 quarters · filed 2026-02-10 | $1.08M derived: sum of 3 quarters · filed 2026-02-10 | $1.44M 10-K · filed 2026-02-10 |
| 2024-09-30 | $360.00K 10-Q · filed 2025-10-23 | $721.00K derived: sum of 2 quarters · filed 2025-10-23 | $1.08M 10-Q · filed 2025-10-23 | $1.63M derived: sum of 4 quarters · filed 2026-02-10 |
| 2024-06-30 | $361.00K 10-Q · filed 2025-07-22 | $722.00K 10-Q · filed 2025-07-22 | $1.27M derived: sum of 3 quarters · filed 2026-02-10 | $1.82M derived: sum of 4 quarters · filed 2026-02-10 |
| 2024-03-31 | $361.00K 10-Q · filed 2025-04-22 | $911.00K derived: sum of 2 quarters · filed 2026-02-10 | $1.46M derived: sum of 3 quarters · filed 2026-02-10 | $2.01M derived: sum of 4 quarters · filed 2026-02-10 |
| 2023-12-31 | $550.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-10 | $1.10M derived: sum of 2 quarters · filed 2026-02-10 | $1.65M derived: sum of 3 quarters · filed 2026-02-10 | $2.20M 10-K · filed 2026-02-10 |
| 2023-09-30 | $549.00K 10-Q · filed 2024-10-22 | $1.10M derived: sum of 2 quarters · filed 2024-10-22 | $1.65M 10-Q · filed 2024-10-22 | $2.49M derived: sum of 4 quarters · filed 2025-02-11 |
| 2023-06-30 | $550.00K 10-Q · filed 2024-07-23 | $1.10M 10-Q · filed 2024-07-23 | $1.94M derived: sum of 3 quarters · filed 2025-02-11 | $2.78M derived: sum of 4 quarters · filed 2025-02-11 |
| 2023-03-31 | $550.00K 10-Q · filed 2024-04-23 | $1.39M derived: sum of 2 quarters · filed 2025-02-11 | $2.23M derived: sum of 3 quarters · filed 2025-02-11 | $3.06M derived: sum of 4 quarters · filed 2025-02-11 |
| 2022-12-31 | $838.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-11 | $1.68M derived: sum of 2 quarters · filed 2025-02-11 | $2.51M derived: sum of 3 quarters · filed 2025-02-11 | $3.35M 10-K · filed 2025-02-11 |
| 2022-09-30 | $838.00K 10-Q · filed 2023-10-24 | $1.68M derived: sum of 2 quarters · filed 2023-10-24 | $2.51M 10-Q · filed 2023-10-24 | $3.79M derived: sum of 4 quarters · filed 2024-02-13 |
| 2022-06-30 | $838.00K 10-Q · filed 2023-07-25 | $1.68M 10-Q · filed 2023-07-25 | $2.96M derived: sum of 3 quarters · filed 2024-02-13 | $4.23M derived: sum of 4 quarters · filed 2024-02-13 |
| 2022-03-31 | $838.00K 10-Q · filed 2023-04-25 | $2.12M derived: sum of 2 quarters · filed 2024-02-13 | $3.40M derived: sum of 3 quarters · filed 2024-02-13 | $4.67M derived: sum of 4 quarters · filed 2024-02-13 |
| 2021-12-31 | $1.28M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-13 | $2.56M derived: sum of 2 quarters · filed 2024-02-13 | $3.84M derived: sum of 3 quarters · filed 2024-02-13 | $5.11M 10-K · filed 2024-02-13 |
| 2021-09-30 | $1.28M 10-Q · filed 2022-10-25 | $2.56M derived: sum of 2 quarters · filed 2022-10-25 | $3.83M 10-Q · filed 2022-10-25 | $5.78M derived: sum of 4 quarters · filed 2023-02-14 |
| 2021-06-30 | $1.28M 10-Q · filed 2022-07-26 | $2.56M 10-Q · filed 2022-07-26 | $4.51M derived: sum of 3 quarters · filed 2023-02-14 | $6.46M derived: sum of 4 quarters · filed 2023-02-14 |
| 2021-03-31 | $1.28M 10-Q · filed 2022-04-26 | $3.23M derived: sum of 2 quarters · filed 2023-02-14 | $5.18M derived: sum of 3 quarters · filed 2023-02-14 | $7.16M derived: sum of 4 quarters · filed 2023-02-14 |
| 2020-12-31 | $1.95M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-14 | $3.90M derived: sum of 2 quarters · filed 2023-02-14 | $5.88M derived: sum of 3 quarters · filed 2023-02-14 | $7.88M 10-K · filed 2023-02-14 |
| 2020-09-30 | $1.95M 10-Q · filed 2021-10-26 | $3.93M derived: sum of 2 quarters · filed 2021-10-26 | $5.93M 10-Q · filed 2021-10-26 | $8.92M derived: sum of 4 quarters · filed 2022-02-15 |
| 2020-06-30 | $1.98M 10-Q · filed 2021-07-27 | $3.98M 10-Q · filed 2021-07-27 | $6.97M derived: sum of 3 quarters · filed 2022-02-15 | $9.97M derived: sum of 4 quarters · filed 2022-02-15 |
| 2020-03-31 | $2.00M 10-Q · filed 2021-04-27 | $4.99M derived: sum of 2 quarters · filed 2022-02-15 | $7.99M derived: sum of 3 quarters · filed 2022-02-15 | $10.98M derived: sum of 4 quarters · filed 2022-02-15 |
| 2019-12-31 | $3.00M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-15 | $5.99M derived: sum of 2 quarters · filed 2022-02-15 | $8.98M derived: sum of 3 quarters · filed 2022-02-15 | $14.83M 10-K · filed 2022-02-15 |
| 2019-09-30 | $3.00M 10-Q · filed 2020-10-27 | $5.99M derived: sum of 2 quarters · filed 2020-10-27 | $11.83M 10-Q · filed 2020-10-27 | $19.22M derived: sum of 4 quarters · filed 2021-02-16 |
| 2019-06-30 | $3.00M 10-Q · filed 2020-07-28 | $8.84M 10-Q · filed 2020-07-28 | $16.23M derived: sum of 3 quarters · filed 2021-02-16 | $23.62M derived: sum of 4 quarters · filed 2021-02-16 |
| 2019-03-31 | $5.84M 10-Q · filed 2020-04-29 | $13.23M derived: sum of 2 quarters · filed 2021-02-16 | $20.62M derived: sum of 3 quarters · filed 2021-02-16 | $28.01M derived: sum of 4 quarters · filed 2021-02-16 |
| 2018-12-31 | $7.39M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-16 | $14.78M derived: sum of 2 quarters · filed 2021-02-16 | $22.17M derived: sum of 3 quarters · filed 2021-02-16 | $29.56M 10-K · filed 2021-02-16 |
| 2018-09-30 | $7.39M 10-Q · filed 2019-10-29 | $14.78M derived: sum of 2 quarters · filed 2019-10-29 | $22.17M 10-Q · filed 2019-10-29 | $31.66M derived: sum of 4 quarters · filed 2020-02-25 |
| 2018-06-30 | $7.39M 10-Q · filed 2019-07-30 | $14.78M 10-Q · filed 2019-07-30 | $24.27M derived: sum of 3 quarters · filed 2020-02-25 | $33.77M derived: sum of 4 quarters · filed 2020-02-25 |
| 2018-03-31 | $7.39M 10-Q · filed 2019-04-30 | $16.89M derived: sum of 2 quarters · filed 2020-02-25 | $26.38M derived: sum of 3 quarters · filed 2020-02-25 | $35.84M derived: sum of 4 quarters · filed 2020-02-25 |
| 2017-12-31 | $9.49M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-25 | $18.99M derived: sum of 2 quarters · filed 2020-02-25 | $28.45M derived: sum of 3 quarters · filed 2020-02-25 | $37.90M 10-K · filed 2020-02-25 |
| 2017-09-30 | $9.50M 10-Q · filed 2018-10-30 | $18.96M derived: sum of 2 quarters · filed 2018-10-30 | $28.41M 10-Q · filed 2018-10-30 | $41.07M derived: sum of 4 quarters · filed 2019-02-26 |
| 2017-06-30 | $9.46M 10-Q · filed 2018-07-31 | $18.91M 10-Q · filed 2018-07-31 | $31.58M derived: sum of 3 quarters · filed 2019-02-26 | $44.25M derived: sum of 4 quarters · filed 2019-02-26 |
| 2017-03-31 | $9.45M 10-Q · filed 2018-05-01 | $22.12M derived: sum of 2 quarters · filed 2019-02-26 | $34.78M derived: sum of 3 quarters · filed 2019-02-26 | $47.45M derived: sum of 4 quarters · filed 2019-02-26 |
| 2016-12-31 | $12.67M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-26 | $25.34M derived: sum of 2 quarters · filed 2019-02-26 | $38.00M derived: sum of 3 quarters · filed 2019-02-26 | $50.67M 10-K · filed 2019-02-26 |
| 2016-09-30 | $12.67M 10-Q · filed 2017-10-31 | $25.34M derived: sum of 2 quarters · filed 2017-10-31 | $38.00M 10-Q · filed 2017-10-31 | $51.13M derived: sum of 4 quarters · filed 2018-02-27 |
| 2016-06-30 | $12.67M 10-Q · filed 2017-08-01 | $25.34M 10-Q · filed 2017-08-01 | $38.46M derived: sum of 3 quarters · filed 2018-02-27 | $54.23M derived: sum of 4 quarters · filed 2018-02-27 |
| 2016-03-31 | $12.67M 10-Q · filed 2017-05-02 | $25.79M derived: sum of 2 quarters · filed 2018-02-27 | $41.57M derived: sum of 3 quarters · filed 2018-02-27 | |
| 2015-12-31 | $13.13M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-27 | $28.90M derived: sum of 2 quarters · filed 2018-02-27 | $63.14M 10-K · filed 2018-02-27 | |
| 2015-09-30 | $15.77M 10-Q · filed 2016-11-03 | $50.02M 10-Q · filed 2016-11-03 | ||
| 2014-12-31 | $56.42M 10-K · filed 2017-02-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) | United States | $14.060B | -43.97 |
| INCYTE CORP (INCY) | United States | $24.855B | 13.14 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| NRC HEALTH (NRC) | United States | $0.450B | 42.50 |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| bioAffinity Technologies, Inc. (BIAF) | United States | $0.063B | |
| OneMedNet Corp (ONMD) | $0.042B | ||
| iSpecimen Inc. (ISPC) | United States | $0.003B | |
| FOXO TECHNOLOGIES INC. (FOXO) | United States | $0.000B | -277.71 |